(Q35352377)

English

Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

0 references

oligosaccharide

1 reference

based on heuristic

inferred from title

Ligilactobacillus salivarius

object named as

Lactobacillus salivarius

1 reference

based on heuristic

inferred from title

author name string

Hemalatha Rajkumar

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Manoj Kumar

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Nilita Das

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

S Nishanth Kumar

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Hanumanth R Challa

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Ravinder Nagpal

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

publication date

20 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Journal of Cardiovascular Pharmacology and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

289-298

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Probiotics in human medicine

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Probiotics, their health benefits and applications for developing healthier foods: a review

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B₁-induced liver carcinogenesis in rats.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

An update on the use and investigation of probiotics in health and disease

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Diabetes, obesity and gut microbiota

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Gut microbiota, enteroendocrine functions and metabolism

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Plasma endotoxin level of healthy donors

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Nutrient-induced inflammation in the intestine

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

A core gut microbiome in obese and lean twins

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Targeting gut microbiota in obesity: effects of prebiotics and probiotics

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

The gut microbiome as therapeutic target

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Probiotics and immune health

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Probiotic properties of Lactobacillus salivarius and closely related Lactobacillus species.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Isolation and characterization of Lactobacillus salivarius MTC 1026 as a potential probiotic.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Lactobacillus salivarius: bacteriocin and probiotic activity.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Composition, diversity, and origin of the bacterial community in grass carp intestine

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Therapeutic effect of probiotic dahi on plasma, aortic, and hepatic lipid profile of hypercholesterolemic rats.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Immunomodulatory effect of probiotic bacteria

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion.

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Probiotics, prebiotics, and synbiotics: gut and beyond

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Probiotic therapy as a novel approach for allergic disease

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Meta-analysis: probiotics in antibiotic-associated diarrhoea

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Anti-obesity effects of gut microbiota are associated with lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Mechanisms of action of probiotics: recent advances

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota

1 reference

https://api.crossref.org/works/10.1177%2F1074248414555004

21 January 2018

Identifiers

10.1177/1074248414555004

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35352377&oldid=1777764141"